MENU
JUN 30, 2020 8:00 AM PDT

Thromboembolism in COVID-19 Laboratory Considerations

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Program Director for Anticoagulation Services, Sanford USD Medical Center & Clinical,Associate Professor, Dept of Internal Medicine, University of South Dakota Sanford School of Medicine

Abstract

To provide a discussion of the thromboembolism risk of COVID-19 and how risk factors relate to laboratory medicine results, the presentation will include case based discussions on how different laboratory values can aid in identifying those at risk of thromboembolic complications.  Further, for patients requiring therapeutic heparin infusions for active thromboembolism treatment, optimal monitoring strategies will be covered, along with the possible need for post discharge prophylaxis.

 

Learning objectives:

  • Describe what is currently known about the etiology and proposed pathophysiology of thromboembolism in COVID-19
  • Identify laboratory parameters that may help identify patients at risk of thromboembolic complications in COVID-19
  • When presented with a COVID-19 case, choose an appropriate thromboembolic prevention strategy
  • When presented with a COVID-19 case with a likely or confirmed thromboembolism, choose an appropriate thromboembolic treatment strategy

 

 

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.  CE credits are available for this webinar up to 2 years from the date of the live broadcast


Show Resources
Show Resources
Attendees
  • See more